Navigation Links
Oregon's Assisted Suicide Law May Overlook Depressed Patients
Date:10/8/2008

Study finds 1 in 4 terminally ill not getting treatment that could influence decision

WEDNESDAY, Oct. 8 (HealthDay News) -- Oregon's physician-assisted suicide law may not adequately protect the one in four terminally ill patients with clinical depression, a new study says.

The Death with Dignity Act was passed by the state in 1997, and there's been intense debate about the extent to which potentially treatable psychiatric disorders may influence a patient's decision to hasten death, according to a news release about the study, published online Oct. 8 by the British Medical Journal.

The act does contain several safeguards to ensure patients are competent to make the decision to end their life, including referral to a psychologist or psychiatrist, if there's concern that a mental illness may be impairing a patient's judgment. However, depression is often overlooked in mentally ill patients.

In 2007, none of the 46 people in Oregon who used physician-assisted suicide were evaluated by a psychologist or psychiatrist, the news release said.

For the new study, researchers at Oregon Health and Sciences University checked for depression or anxiety in 58 terminally ill patients who'd requested physician-assisted suicide or had contacted an assisted death organization. Fifteen of the patients met the criteria for depression and 13 for anxiety.

By the end of the study, 42 patients had died. Of those, 18 received a prescription for a lethal medication, and nine died by lethal ingestion. Of those who received a prescription for a lethal medication, three met the criteria for depression. All three died by lethal ingestion within two months of being assessed by researchers.

While most patients who request physician-assisted suicide do not have a depressive disorder, the study authors suggested that "the current practice of Death with Dignity Act may not adequately protect all mentally ill patients." The authors called for "increased vigilance and systematic examination for depression among patients who may access legalized aid in dying."

While it's important to protect vulnerable patients, it can be difficult to determine if depression is impairing the judgment of terminally ill patients, Dr. Marije van der Lee, of the Helen Dowling Institute in the Netherlands, wrote in an accompanying editorial.

Depression doesn't necessarily impair judgment, van der Lee said. "We should focus on trying to 'protect' patients from becoming depressed in the first place, rather than focus on protecting patients from assisted suicide," she wrote.

More information

The U.S. National Cancer Institute has information about end-of-life issues.



-- Robert Preidt



SOURCE: British Medical Journal, news release, Oct. 8, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Assisted Suicide Proponents Seek to Expand With New 1-800 Suicide Consultations
2. Revision: Ziehm Imaging and BrainLAB Announce Partnership for Intra-Operative 3D Imaging and Computer Assisted Surgery (CAS)
3. Californians Against Assisted Suicide: Assisted Suicide Study From Biased Author is Questionable at Best
4. Vulnerable groups are not at higher risk of physician-assisted death
5. Assisted Suicide Wont Up Deaths for Vulnerable Groups: Study
6. American Humane Association Adds Direct Services in Animal-Assisted Activities and Therapy
7. Turning Pointe Therapeutic Riding Recognized for Excellence in Providing Equine-Assisted Therapies to People with Disabilities
8. Play by Steve Nash, Assisted by Milk
9. CoolTouch Introduces CoolLipo(TM) Laser System, Recently FDA Cleared for Laser-Assisted Lipolysis
10. Assisted Living Federation Challenges Presidential Candidates
11. Peninsula United Methodist Homes Completes Enterprise-Wide Deployment of AccuNurse Voice-Assisted Care
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Oregon's Assisted Suicide Law May Overlook Depressed Patients
(Date:4/28/2017)... ... April 28, 2017 , ... ... of the GlycoMark test throughout the Northeast U.S. , GlycoMark is the ... diabetes. The GlycoMark test provides a clinically proven one- to two-week measure of ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... been previously exposed to more adverse experiences than children in the general population. ... such as abuse, neglect or other family challenges. While no fault of their ...
(Date:4/28/2017)... ... ... Bill Howe started his sewer and drain company in 1980 focusing heavily ... team, the Bill Howe brand was born and they began cultivating their mission to ... the San Diego community in which they worked, lived and were raising their daughters. ...
(Date:4/28/2017)... ... April 28, 2017 , ... Woolsy Corporation Limited, a leading ... Nova Skin Sciences division, recently announced the launch of Allumière Antiaging Cream, a ... of an anti-aging concentrate. , Anogeissus Leiocarpa Bark Extract and Vitamin ...
(Date:4/27/2017)... and DENVER (PRWEB) , ... April 27, 2017 ... ... Health, the nation’s leading respiratory hospital, based in Denver, Colorado, announced an agreement ... is enabled by the continuing support of the Jane and Leonard Korman Family ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  Cogentix Medical, ... focused on providing the Urology, Uro/Gyn and Gynecology ... that Ash Keswani has joined the Company as ... this newly created position, Mr. Keswani will report ... CEO. "Our organization is delighted that ...
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... , April 20, 2017  AbbVie (NYSE: ABBV), ... percent (n=145/146) of chronic hepatitis C virus (HCV) ... or 6 and compensated cirrhosis (Child-Pugh A) achieved ... 12 ) with its investigational, pan-genotypic regimen of ... were seen following 12 weeks of G/P treatment ...
Breaking Medicine Technology: